Drug molecules of marine origin

Area of Science:

• Marine Biology
• Pharmacology
• Biomedical Research

Background:

• Marine organisms are a rich source of novel chemical compounds with potential therapeutic applications.
• Despite promising discoveries in marine molecule chemistry and pharmacology during the 1980s, research investment remains limited.
• Current R&D funding from industry and governments for marine-derived pharmacologically active substances is insufficient.

Purpose of the Study:

• To highlight the untapped biomedical potential of marine organisms.
• To critically appraise the existing literature on marine-derived molecules.
• To emphasize the need for increased research efforts in marine pharmacology.

Main Methods:

• Literature appraisal of marine molecule chemistry and pharmacology.
• Analysis of current R&D investment trends in the field.
• Identification of challenges and opportunities in developing marine-derived drugs.

Main Results:

• Numerous fascinating marine molecules with unusual and potent activities have been identified.
• The development of clinical drugs from marine sources is significantly hindered by inadequate research.
• A substantial gap exists between the discovery of marine compounds and their clinical application.

Conclusions:

• Marine organisms represent a vast, underexplored resource for novel drug discovery.
• A significant and concerted effort from academic, industrial, and governmental sectors is required.
• Increased investment and collaboration are essential to accelerate the translation of marine molecules into clinical therapies.